Main Article Content
Aims: Atenolol is one of the β-blockers widely used for the treatment of hypertension and other cardiovascular diseases. To simplify the methods for determining of drugs concentrations in blood and plasma the dried spots assays (dried blood spots or dried plasma spots) could be used. In this case high sensitive detector like mass-spectrometer is required as well as high level of drug recovery from dried spot. In this study the extraction of atenolol from dried plasma spots (DPS) was studied to offer the optimum parameters of extraction method.
Study Design: Short research articles.
Place and Duration of Study: Core Facility of Mass Spectrometric Analysis, Institute of Chemical Biology and Fundamental Medicine SB RAS, between January and October 2019.
Methodology: The organic extraction method was chosen for evaluation as the most suitable for LC-MS assay. Several parameters: % of organic solvent, presence or absence of 0.1% formic acid, time, volume and temperature of extraction were investigated to find the best combination for atenolol recovery from DPS for further LC-MS analysis.
Results: Results showed that the solvent composition and temperature has main influence on the extraction. The effect of extraction time and volume of solvent have no significant influence on atenolol recovery. Pure acetonitrile is the worst solvent for atenolol extraction from DPS. The solvents: MeOH:H2O (60:40, v:v), MeOH:0.1% FA in H2O (60:40, v:v), ACN:0.1% FA in H2O (50:50, v:v) or ACN:MeOH (60:40, v:v) provide the best recovery of atenolol. The optimum extraction temperature is 40°C, time of extraction is 15-30 min and volume of solvent - 200-300 μL.
Conclusion: Several solvents acceptable for LC-MS analysis with optimized recovery parameter from DPS can be used for routine extraction of atenolol.
Chernonosov A. The Use of dried blood spots for the quantification of antihypertensive drugs. Int J Anal Chem. 2018;2018:3235072.
Campbell DJ, Mcgrady M, Prior DL, Coller JM, Boffa U, Shiel L, et al. Most individuals with treated blood pressures above target receive only one or two antihypertensive drug classes. Intern Med J. 2013;43:137–43.
Lawson G, Cocks E, Tanna S. Quantitative Determination of atenolol in dried blood spot samples by Lc-Hrms: A potential method for assessing medication adherence. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;897:72–9.
Pandya HC, Spooner N, Mulla H. Dried Blood Spots, Pharmacokinetic Studies And Better Medicines For Children. Bioanalysis. 2011;3:779–86.
Li W, Tse FLS. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomed Chromatogr. 2010;24:49–65.
Parker SP, Cubitt WD. The use of the dried blood spot sample in epidemiological studies. J Clin Pathol. 1999;52:633– 9.
La Marca G, Malvagia S, Filippi L, Luceri F, Moneti G, Guerrini R. A new rapid micromethod for the assay of phenobarbital from dried blood spots by Lc-tandem mass spectrometry. Epilepsia. 2009;50:2658–62.
Chernonosov A. Quantification of warfarin in dried rat plasma spots by high-performance liquid chromatography with tandem mass spectrometry. Journal of Pharmaceutics. 2016;2016:1–6.
Spooner N, Lad R, Barfield M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: Considerations for the validation of a quantitative bioanalytical method. Anal Chem. 2009;81:1557–63.
Patel P, Tanna S, Mulla H, Kairamkonda V, Pandya H, Lawson G. Dexamethasone quantification in dried blood spot samples using LC-MS: The potential for application to neonatal pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:3277–82.
Suyagh MF, Iheagwaram G, Kole PL, Millership J, Collier P, Halliday H, Mcelnay JC. Development and validation of a dried blood spot-HPLC assay for the determination of metronidazole in neonatal whole blood samples. Anal Bioanal Chem. 2010;397:687–93.
Wong P, Pham R, Bruenner BA, James CA. Increasing Efficiency for dried blood spot analysis: Prospects For automation and simplified sample analysis. Bioanalysis. 2010;2:1787–9.
Van Der Heijden J, Beer Y De, Hoogtanders K, Christiaans M, Jong GJ De, Neef C, Stolk L. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 2009;50:664–70.
Edelbroek PM, Van Der Heijden J, Stolk LML. Dried blood spot methods in therapeutic drug monitoring: Methods, assays, and pitfalls. Ther Drug Monit. 2009;31:327–36. DOI: 10.1097/FTD.0b013e31819e91ce
Kim HM, Park J-H, Long NP, Kim DD, Kwon SW. Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry. Journal of Food and Drug Analysis. 2019;27:906–14.
Dennis Bernieh ST. LC-HRMS analysis of dried blood spot samples for assessing adherence to cardiovascular medications. J Bioanal Biomed; 2015.
Bernieh D, Lawson G, Tanna S. Quantitative LC-HRMS determination of selected cardiovascular drugs, in dried blood spots, as an indicator of adherence to medication. J Pharm Biomed Anal. 2017;142:232–43.